|
|
||||||||


*
Department of Biochemistry and Cell Biology, Institute for Cell and Developmental Biology, State University of New York, Stony Brook, NY 11794;
Laboratory for Immunological Research, Schering-Plough, Dardilly, France;
Department of Pathology, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814; and
§
Department of Immunological Diseases, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877
Maturing B lymphocytes possess a recombination activity that
switches the class of heavy chain Ig. The nature of the recombination
activity, its molecular requirements and regulation remain elusive
questions about B lymphocyte biology and development. Class switch
recombination is controlled by cytokine response elements that are
required to differentially activate CH gene transcription
before their subsequent recombination. Here, we show that cultures of
purified murine and human B cells, stimulated only by CD40 receptor
engagement, possess a potent switch recombination activity. CD40
ligand-stimulated murine and human B lymphocytes were infected with
recombinant retroviruses containing Sµ and S
2b sequences.
Chromosomally integrated switch substrate retrovectors (SSRs),
harboring constitutively transcribed S sequences, underwent extensive
recombinations restricted to their S sequences with structural features
akin to endogenous switching. SSR recombination commenced 4 days
postinfection (5 days poststimulation) with extensive switch sequence
recombination over the next 2 to 3 days. In contrast, endogenous S
2b
and S
1 sequences did not undergo appreciable switch recombination
upon CD40 signaling alone. As expected, IL-4 induced endogenous Sµ to
S
1 switching, while endogenous Sµ to S
2b fusions remained
undetectable. Surprisingly, IL-4 enhanced the onset of SSR
recombination in CD40-stimulated murine B cells, with S-S products
appearing only 2 days postinfection and reaching a maximum within 2 to
3 days. The efficiency of switch recombination with SSRs ressembles
that seen for endogenous CH class
switching.
This article has been cited by other articles:
![]() |
K. Basso, U. Klein, H. Niu, G. A. Stolovitzky, Y. Tu, A. Califano, G. Cattoretti, and R. Dalla-Favera Tracking CD40 signaling during germinal center development Blood, December 15, 2004; 104(13): 4088 - 4096. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bovia, P. Salmon, T. Matthes, K. Kvell, T. H. Nguyen, C. Werner-Favre, M. Barnet, M. Nagy, F. Leuba, J.-F. Arrighi, et al. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors Blood, March 1, 2003; 101(5): 1727 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Luby, C. E. Schrader, J. Stavnezer, and E. Selsing The {micro} Switch Region Tandem Repeats Are Important, but Not Required, for Antibody Class Switch Recombination J. Exp. Med., January 15, 2001; 193(2): 159 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shanmugam, M.-J. Shi, L. Yauch, J. Stavnezer, and A. L. Kenter Evidence for Class-Specific Factors in Immunoglobulin Isotype Switching J. Exp. Med., April 17, 2000; 191(8): 1365 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-j. Li and N. Maizels Activation and Targeting of Immunoglobulin Switch Recombination by Activities Induced by EBV Infection J. Immunol., December 15, 1999; 163(12): 6659 - 6664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stavnezer, S. P. Bradley, N. Rousseau, T. Pearson, A. Shanmugam, D. J. Waite, P. R. Rogers, and A. L. Kenter Switch Recombination in a Transfected Plasmid Occurs Preferentially in a B Cell Line That Undergoes Switch Recombination of Its Chromosomal Ig Heavy Chain Genes J. Immunol., August 15, 1999; 163(4): 2028 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Schrader, W. Edelmann, R. Kucherlapati, and J. Stavnezer Reduced Isotype Switching in Splenic B Cells from Mice Deficient in Mismatch Repair Enzymes J. Exp. Med., August 2, 1999; 190(3): 323 - 330. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |